Literature DB >> 10791956

Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1beta. Role of C/EBP factors.

C Massaad1, M Paradon, C Jacques, C Salvat, G Bereziat, F Berenbaum, J L Olivier.   

Abstract

Secreted type IIA phospholipase A(2), which is involved in arachidonic acid release, is abundantly produced by chondrocytes and secreted in the synovial fluids of patients affected by rheumatoid arthritis. Transfection experiments showed that interleukin-1beta stimulates the phospholipase A(2) [-1614; +20] promoter activity by 6-7-fold and that the [-210; -176] fragment is critical for this stimulation. CAAT enhancer-binding protein (C/EBP) beta and C/EBPdelta transcription factors bind to this element as shown by bandshift experiments. Interleukin-1beta increased the levels of C/EBPdelta mRNA as soon as 2 h and up to 24 h without affecting those of C/EBPbeta. Higher amounts of C/EBPdelta proteins correlate with the stimulation of C/EBPdelta mRNA. Mutations or 5' deletions in the upstream [-247; -210] region reduced by 2-fold the basal and interleukin-1beta-stimulated transcription activities. Two types of factors bind to overlapping sequences on this fragment: NF1-like proteins and the glucocorticoid receptor. The glucocorticoid receptor is responsible for a moderate stimulation of the promoter activity by dexamethasone and may interact with C/EBP factors to achieve a full transcription activity in basal conditions and in the presence of interleukin-1beta. A [-114; -85] proximal regulatory element forms three complexes in bandshift experiments, the slowest mobility one involving the Sp1 zinc finger factor. Mutation of this sequence reduced to 2-fold the stimulation of the promoter activity by interleukin-1beta or the C/EBP factors. Induction of the transcription of secreted type IIA phospholipase A(2) gene by interleukin-1beta in chondrocytes absolutely requires C/EBPbeta and C/EBPdelta factors but does not involve NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791956     DOI: 10.1074/jbc.M001250200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells.

Authors:  Cosima Fonte; Julien Grenier; Amalia Trousson; Anne Chauchereau; Olivier Lahuna; Etienne-Emile Baulieu; Michael Schumacher; Charbel Massaad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

2.  CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.

Authors:  Katherine J Motyl; Michelle Raetz; Srinivasan Arjun Tekalur; Richard C Schwartz; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

3.  Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.

Authors:  Pragya Sharma; Shalini Thakran; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

4.  Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Heike Kostka; Graeme Eisenhofer; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

5.  Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells.

Authors:  Sun Ae Han; Sahnghoon Lee; Sang Cheol Seong; Myung Chul Lee
Journal:  Tissue Eng Part A       Date:  2014-07-22       Impact factor: 3.845

6.  Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.

Authors:  Valérie Antonio; Arthur Brouillet; Brigitte Janvier; Claire Monne; Gilbert Bereziat; Marise Andreani; Michel Raymondjean
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states.

Authors:  Nicholas Knowlton; Kaiyu Jiang; Mark Barton Frank; Amita Aggarwal; Carol Wallace; Ryan McKee; Brad Chaser; Catherine Tung; Laura Smith; Yanmin Chen; Jeanette Osban; Kathleen O'Neil; Michael Centola; Julie L McGhee; James N Jarvis
Journal:  Arthritis Rheum       Date:  2009-03

8.  Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism.

Authors:  Michael S Kuefner; Kevin Pham; Jeanna R Redd; Erin J Stephenson; Innocence Harvey; Xiong Deng; Dave Bridges; Eric Boilard; Marshall B Elam; Edwards A Park
Journal:  J Lipid Res       Date:  2017-06-29       Impact factor: 5.922

Review 9.  The many faces of C/EBPδ and their relevance for inflammation and cancer.

Authors:  Kuppusamy Balamurugan; Esta Sterneck
Journal:  Int J Biol Sci       Date:  2013-09-20       Impact factor: 6.580

10.  C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57.

Authors:  Makoto Hirata; Fumitaka Kugimiya; Atsushi Fukai; Shinsuke Ohba; Naohiro Kawamura; Toru Ogasawara; Yosuke Kawasaki; Taku Saito; Fumiko Yano; Toshiyuki Ikeda; Kozo Nakamura; Ung-Il Chung; Hiroshi Kawaguchi
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.